New study aims to uncover why some kidney patients Don't get better

NCT ID NCT06926244

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 02, 2026 · Last updated Jun 13, 2026 · Updated 3 times

Summary

This study follows 800 adults with IgA nephropathy, a kidney disease, to see how well current treatments work in everyday medical practice. Researchers want to understand why some patients still have protein in their urine or worsening kidney function despite standard care. The goal is to find better ways to manage the disease and prevent kidney failure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nephrology department, Hospital Pitié - Salpêtrière (ASSISTANCE PUBLIQUE HOPITAUX DE PARIS AP-HP)
RECRUITING

Paris, 75013, France

Conditions

Explore the condition pages connected to this study.

IGA NEPHROPATHY (IGAN)

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

IGA NEPHROPATHY